Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: -0.25 (-2.50%)
Spread: 0.50 (5.263%)
Open: 10.15
High: 10.15
Low: 9.75
Prev. Close: 10.00
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Jun 2017 10:38

RNS Number : 6698H
SkinBioTherapeutics PLC
09 June 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SkinBioTherapeutics

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

NO

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

NO

An event changing the breakdown of voting rights

NO

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

SPREADEX LTD

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

30/05/2017

6. Date on which issuer notified:

08/06/2017

7. Threshold(s) that is/are crossed orreached: vi, vii

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1 -

3,233,333

3,233,333

2,933,333

2,933,333

2.47%

GB00BF33H870

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

CFD/SPREADBET

501,445

0.42%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,434,778

2.89%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

DAVID CORBEN

15. Contact telephone number:

01727 895135

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFLMLTMBJMMFR
Date   Source Headline
29th Oct 20214:36 pmRNSPrice Monitoring Extension
29th Oct 20217:00 amRNSCommercial Launch of AxisBiotix-Ps™
15th Oct 20219:00 amRNSInvestor Presentation
30th Sep 20217:00 amRNSAxisBiotix-Ps™ Psoriasis Food Supplement Launch
7th Sep 20217:00 amRNSHolding(s) in Company
19th Aug 202111:00 amRNSBusiness Update - Correction
19th Aug 20217:00 amRNSBusiness Update
26th May 202111:10 amRNSHolding(s) in Company
26th May 20217:00 amRNSPositive data for AxisBiotix-Ps™ consumer study
18th May 202111:00 amRNSPrice Monitoring Extension
27th Apr 20217:00 amRNSInitiation of oral health development programme
19th Apr 20213:09 pmRNSHolding(s) in Company
12th Apr 202111:05 amRNSSecond Price Monitoring Extn
12th Apr 202111:00 amRNSPrice Monitoring Extension
8th Apr 20217:00 amRNSResearch programme with University of Manchester
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
6th Apr 20212:06 pmRNSSecond Price Monitoring Extn
6th Apr 20212:01 pmRNSPrice Monitoring Extension
18th Mar 20212:02 pmRNSHolding(s) in Company
16th Mar 20215:42 pmRNSHolding(s) in Company
16th Mar 202110:50 amRNSHolding(s) in Company
15th Mar 20211:43 pmRNSExercise of Warrant
15th Mar 20217:00 amRNSHalf-year Report
12th Mar 20212:05 pmRNSSecond Price Monitoring Extn
12th Mar 20212:00 pmRNSPrice Monitoring Extension
17th Feb 202111:36 amRNSAxisBiotix-Ps™ food supplement study commences
9th Feb 20211:04 pmRNSHolding(s) in Company
5th Feb 202111:05 amRNSSecond Price Monitoring Extn
5th Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 202111:21 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSExpanded enrolment for AxisBiotix-Ps™ study
25th Jan 20219:05 amRNSSecond Price Monitoring Extn
25th Jan 20219:00 amRNSPrice Monitoring Extension
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20211:49 pmRNSHolding(s) in Company
19th Jan 20213:14 pmRNSHolding(s) in Company
18th Jan 20214:08 pmRNSHolding(s) in Company
13th Jan 20217:00 amRNSEnrolment for AxisBiotix-Ps™ study commences
11th Jan 202111:06 amRNSSecond Price Monitoring Extn
11th Jan 202111:00 amRNSPrice Monitoring Extension
7th Jan 20214:41 pmRNSSecond Price Monitoring Extn
7th Jan 20214:35 pmRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
29th Dec 20202:06 pmRNSSecond Price Monitoring Extn
29th Dec 20202:01 pmRNSPrice Monitoring Extension
29th Dec 202012:59 pmRNSResult of AGM
4th Dec 20204:44 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.